Literature DB >> 19233030

Electrical impedance myography as a biomarker for ALS.

Seward Rutkove.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19233030      PMCID: PMC2719292          DOI: 10.1016/S1474-4422(09)70030-4

Source DB:  PubMed          Journal:  Lancet Neurol        ISSN: 1474-4422            Impact factor:   44.182


× No keyword cloud information.
  5 in total

1.  Electrical impedance myography to assess outcome in amyotrophic lateral sclerosis clinical trials.

Authors:  Seward B Rutkove; Hui Zhang; David A Schoenfeld; Elizabeth M Raynor; Jeremy M Shefner; Merit E Cudkowicz; Anne B Chin; Ronald Aaron; Carl A Shiffman
Journal:  Clin Neurophysiol       Date:  2007-09-25       Impact factor: 3.708

2.  Assessing neuromuscular disease with multifrequency electrical impedance myography.

Authors:  Gregory J Esper; Carl A Shiffman; Ronald Aaron; Kyungmouk S Lee; Seward B Rutkove
Journal:  Muscle Nerve       Date:  2006-11       Impact factor: 3.217

3.  Localized bioimpedance analysis in the evaluation of neuromuscular disease.

Authors:  Seward B Rutkove; Ronald Aaron; Carl A Shiffman
Journal:  Muscle Nerve       Date:  2002-03       Impact factor: 3.217

4.  Discriminating neurogenic from myopathic disease via measurement of muscle anisotropy.

Authors:  Lindsay P Garmirian; Anne B Chin; Seward B Rutkove
Journal:  Muscle Nerve       Date:  2009-01       Impact factor: 3.217

Review 5.  Biomarkers in amyotrophic lateral sclerosis.

Authors:  Martin R Turner; Matthew C Kiernan; P Nigel Leigh; Kevin Talbot
Journal:  Lancet Neurol       Date:  2009-01       Impact factor: 44.182

  5 in total
  6 in total

1.  The preclinical discovery of amyotrophic lateral sclerosis drugs.

Authors:  Marcie A Glicksman
Journal:  Expert Opin Drug Discov       Date:  2011-10-25       Impact factor: 6.098

Review 2.  Use of biomarkers in ALS drug development and clinical trials.

Authors:  Nadine Bakkar; Ashley Boehringer; Robert Bowser
Journal:  Brain Res       Date:  2014-10-24       Impact factor: 3.252

3.  Electrical impedance myography in the evaluation of the tongue musculature in amyotrophic lateral sclerosis.

Authors:  Sanjana Shellikeri; Yana Yunusova; Jordan R Green; Gary L Pattee; James D Berry; Seward B Rutkove; Lorne Zinman
Journal:  Muscle Nerve       Date:  2015-06-03       Impact factor: 3.217

Review 4.  Biomarkers in amyotrophic lateral sclerosis: opportunities and limitations.

Authors:  Robert Bowser; Martin R Turner; Jeremy Shefner
Journal:  Nat Rev Neurol       Date:  2011-10-11       Impact factor: 42.937

5.  Non-invasive evaluation of muscle disease in the canine model of Duchenne muscular dystrophy by electrical impedance myography.

Authors:  Chady H Hakim; Alex Mijailovic; Thais B Lessa; Joan R Coates; Carmen Shin; Seward B Rutkove; Dongsheng Duan
Journal:  PLoS One       Date:  2017-03-24       Impact factor: 3.240

6.  Biomarkers of sarcopenia in clinical trials-recommendations from the International Working Group on Sarcopenia.

Authors:  Matteo Cesari; Roger A Fielding; Marco Pahor; Bret Goodpaster; Marc Hellerstein; Gabor A van Kan; Stefan D Anker; Seward Rutkove; J Willem Vrijbloed; Maria Isaac; Yves Rolland; Christine M'rini; Mylène Aubertin-Leheudre; Jesse M Cedarbaum; Mauro Zamboni; Cornell C Sieber; Didier Laurent; William J Evans; Ronenn Roubenoff; John E Morley; Bruno Vellas
Journal:  J Cachexia Sarcopenia Muscle       Date:  2012-08-03       Impact factor: 12.910

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.